RAAA yields 3.55% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, RAAA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RAAA + JNJ for your $10,000?
RAAA uses up to 50% leverage through reverse repurchase agreements to increase exposure to USDdenominated collateralized loan obligations (CLOs). It seeks income and capital preservation by focusing on AAArated CLO tranches, the senior and highestquality part of a CLO structure backed by pools of loans, including leveraged loans. CLOs must be rated AAA or deemed comparable by the adviser. Up to 20% of assets may be allocated to AA or Arated CLOs. A bottomup process evaluates manager skill, deal structure, collateral, cash flow, and trading frequency, emphasizing larger and more liquid transactions. Investments may also include ETFs with similar strategies. Most holdings are floatingrate and sourced from both primary and secondary markets, with allocations adjusted based on market trends. The fund is nondiversified but limits holdings of any single CLO or manager to 20% to help manage risk while pursuing income and credit quality.
Full RAAA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.